Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Long-Term, Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects

NCT02610868 is registered in ClinicalTrials.gov with Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC as lead sponsor.

NCT NCT02610868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02610868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Long-Term, Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects
Lead sponsor
Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2015
Completion date
June 30, 2017
Enrollment
187 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

sialorrhea